Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice

Molecular Nutrition and Food Research

Volumn 59, Issue 5, 2015, Pages 927-938

  Grossin, Nicolas ^a   Auger, Florent ^a   Niquet Leridon, Céline ^b   Durieux, Nicolas ^a   Montaigne, David ^a   Schmidt, Ann Marie ^c   Susen, Sophie ^a   Jacolot, Philippe ^b   Beuscart, Jean Baptiste ^d   Tessier, Frédéric J ^b   Boulanger, Eric ^a  

^a UNIV LILLE   (France)

^b INSTITUT POLYTECHNIQUE LASALLE BEAUVAIS   (France)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Faculté de Médecine Pôle Recherché   (France)

Author keywords

Aging; Aorta; Endothelium; Glycation; Nutrition

Indexed keywords

ANIMALIA; MUS;

ADVANCED GLYCATION END PRODUCT RECEPTOR; LYSINE; N(6)-CARBOXYMETHYLLYSINE; PROTEIN INTAKE; SIRT1 PROTEIN, MOUSE; SIRTUIN 1; VASCULAR CELL ADHESION MOLECULE 1;

ADMINISTRATION AND DOSAGE; AGING; ANALOGS AND DERIVATIVES; ANIMAL; ARTERIAL STIFFNESS; ARTERY; C57BL MOUSE; MALE; MOUSE; PHYSIOLOGY; PROTEIN INTAKE; PULSE WAVE; VASCULAR ENDOTHELIUM;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGING; ANIMALS; ARTERIES; DIETARY PROTEINS; ENDOTHELIUM, VASCULAR; LYSINE; MALE; MICE; MICE, INBRED C57BL; PULSE WAVE ANALYSIS; SIRTUIN 1; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR STIFFNESS;

EID: 84928761407     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400643     Document Type: Article

References (39)

1. Greenwald, S. E., Ageing of the conduit arteries. J. Pathol. 2007, 211, 157-172.
2. Delgado-Andrade, C., Seiquer, I., Navarro, M. P., Morales, F. J., Maillard reaction indicators in diets usually consumed by adolescent population. Mol. Nutr. Food Res. 2007, 51, 341-351.
3. Uribarri, J., Cai, W., Sandu, O., Peppa, M., Goldberg, T. et al., Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann. N Y Acad. Sci. 2005, 1043, 461-466.
4. Foerster, A., Henle, T., Glycation in food and metabolic transit of dietary AGEs (advanced glycation end-products): studies on the urinary excretion of pyrraline. Biochem Soc. Trans. 2003, 31, 1383-1385.
5. Delgado-Andrade, C., Tessier, F. J., Niquet-Leridon, C., Seiquer, I. et al., Study of the urinary and faecal excretion of N (ε)-carboxymethyllysine in young human volunteers. Amino Acids 2012, 43, 595-602.
6. Tessier, F. J., Birlouez-Aragon, I., Health effects of dietary Maillard reaction products: the results of ICARE and other studies. Amino Acids 2012, 42, 1119-1131.
7. Delatour, T., Hegele, J., Parisod, V., Richoz, J. et al., Analysis of advanced glycation endproducts in dairy products by isotope dilution liquid chromatography-electrospray tandem mass spectrometry. The particular case of carboxymethyllysine. J. Chromatogr. A 2009, 1216, 2371-2381.
8. Goldin, A., Beckman, J. A., Schmidt, A. M., Creager, M. A., Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006, 114, 597-605.
9. Grossin, N., Wautier, J. L., Protein glycation and endothelium dysfunction. J. Soc. Biol. 2007, 201, 175-184.
10. Aronson, D., Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J. Hypertens. 2003, 21, 3-12.
11. Sell, D. R., Monnier, V. M., Molecular basis of arterial stiffening: role of glycation-a mini-review. Gerontology 2012, 58, 227-237.
12. Kass, D. A., Shapiro, E. P., Kawaguchi, M., Capriotti, A. R. et al., Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001, 104, 1464-1470.
13. Grossin, N., Wautier, M. P., Wautier, J. L., Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide. Biorheology 2009, 46, 63-72.
14. Schmidt, A. M., Vianna, M., Gerlach, M., Brett, J. et al., Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 1992, 267, 14987-14997.
15. Boulanger, E., Wautier, M. P., Wautier, J. L., Boval, B. et al., AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int. 2002, 61, 148-156.
16. Boulanger, E., Grossin, N., Wautier, M. P., Taamma, R. et al., Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation. Kidney Int. 2007, 71, 126-133.
17. Roca, F., Grossin, N., Chassagne, P., Puisieux, F. et al., Glycation: the angiogenic paradox in aging and age-related disorders and diseases. Ageing Res. Rev. 2014, 15, 146-160.
18. Stirban, A., Negrean, M., Gotting, C., Uribarri, J. et al., Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines. Ann. N Y Acad. Sci. 2008, 1126, 276-279.
19. Cai, W., He, J. C., Zhu, L., Chen, X. et al., Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am. J. Pathol. 2008, 173, 327-336.
20. Patel, R., Baker, S. S., Liu, W., Desai, S. et al., Effect of dietary advanced glycation end products on mouse liver. PLoS One 2012, 7, e35143.
21. Bulckaen, H., Prevost, G., Boulanger, E., Robitaille, G. et al., Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging. Am. J. Physiol. Heart Circ. Physiol. 2008, 294, H1562-H1570.
22. Prevost, G., Bulckaen, H., Gaxatte, C., Boulanger, E. et al., Structural modifications in the arterial wall during physiological aging and as a result of diabetes mellitus in a mouse model: are the changes comparable? Diabetes Metab. 2011, 37, 106-111.
23. Faist, V., Muller, C., Drusch, S., Erbersdobler, H. F., Selective fortification of lysinoalanine, fructoselysine and N epsilon-carboxymethyllysine in casein model systems. Nahrung 2001, 45, 218-221.
24. Schmitt, A., Schmitt, J., Munch, G., Gasic-Milencovic, J., Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics. Anal. Biochem. 2005, 338, 201-215.
25. Niquet-Leridon, C., Tessier, F., Quantification of Nε-carboxymethyl-lysine in selected chocolate-flavoured drink mixes using high-performance liquid chromatography-linear ion trap tandem mass spectrometry. Food Chem. 2011, 126, 655-663.
26. Matsumoto, S., Yoshida, T., Murata, H., Harada, S. et al., Solution structure of the variable-type domain of the receptor for advanced glycation end products: new insight into AGE-RAGE interaction. Biochemistry 2008, 47, 12299-12311.
27. Uribarri, J., Woodruff, S., Goodman, S., Cai, W. et al., Advanced glycation end products in foods and a practical guide to their reduction in the diet. J. Am. Diet. Assoc. 2010, 110, 911-16e12.
28. Wautier, M. P., Chappey, O., Corda, S., Stern, D. M. et al., Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab. 2001, 280, E685-E694.
29. Grossin, N., Wautier, M. P., Picot, J., Stern, D. M. et al., Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms. Diabetes Metab. 2009, 35, 410-417.
30. Grossin, N., Boulanger, E., Wautier, M. P., Wautier, J. L., The different isoforms of the receptor for advanced glycation end products are modulated by pharmacological agents. Clin. Hemorheol. Microcirc. 2010, 45, 143-153.
31. Freidja, M. L., Tarhouni, K., Toutain, B., Fassot, C. et al., The AGE-breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes. Diabetes 2012, 61, 1562-1572.
32. Chao, P. C., Huang, C. N., Hsu, C. C., Yin, M. C. et al., Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1alpha and MCP-1 levels in type 2 diabetic patients. Eur. J. Nutr. 2010, 49, 429-434.
33. Uribarri, J., Peppa, M., Cai, W., Goldberg, T. et al., Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J. Am. Soc. Nephrol. 2003, 14, 728-731.
34. Cai, W., Ramdas, M., Zhu, L., Chen, X. et al., Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc. Natl. Acad. Sci. USA 2012, 109, 15888-15893.
35. Hofmann, S. M., Dong, H. J., Li, Z., Cai, W. et al., Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 2002, 51, 2082-2089.
36. Hellwig, M., Geissler, S., Matthes, R., Peto, A. et al., Transport of free and peptide-bound glycated amino acids: synthesis, transepithelial flux at Caco-2 cell monolayers, and interaction with apical membrane transport proteins. Chembiochem 2011, 12, 1270-1279.
37. Guarente, L., Sirtuins in aging and disease. Cold Spring Harb. Symp. Quant. Biol. 2007, 72, 483-488.
38. Mattagajasingh, I., Kim, C. S., Naqvi, A., Yamamori, T. et al., SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 2007, 104, 14855-14860.
39. Cai, W., Uribarri, J., Zhu, L., Chen, X. et al., Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc. Natl. Acad. Sci. USA 2014, 111, 4940-4945.